Capital International Investors Reduces Holdings in Relx Plc (NYSE:RELX)

Capital International Investors lessened its stake in Relx Plc (NYSE:RELX - Free Report) by 1.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 6,433,301 shares of the technology company's stock after selling 62,886 shares during the quarter. Capital International Investors owned about 0.35% of Relx worth $292,113,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. NewEdge Advisors LLC grew its holdings in shares of Relx by 19.9% in the fourth quarter. NewEdge Advisors LLC now owns 39,900 shares of the technology company's stock valued at $1,812,000 after purchasing an additional 6,616 shares during the period. Evergreen Capital Management LLC increased its stake in Relx by 4.3% during the fourth quarter. Evergreen Capital Management LLC now owns 14,355 shares of the technology company's stock worth $652,000 after acquiring an additional 586 shares during the last quarter. Guggenheim Capital LLC raised its position in Relx by 11.3% in the fourth quarter. Guggenheim Capital LLC now owns 23,222 shares of the technology company's stock valued at $1,055,000 after purchasing an additional 2,350 shares during the period. Causeway Capital Management LLC grew its holdings in shares of Relx by 9.8% during the 4th quarter. Causeway Capital Management LLC now owns 465,886 shares of the technology company's stock worth $21,161,000 after purchasing an additional 41,476 shares during the period. Finally, Comgest Global Investors S.A.S. raised its holdings in Relx by 30.8% in the 4th quarter. Comgest Global Investors S.A.S. now owns 55,284 shares of the technology company's stock valued at $2,511,000 after buying an additional 13,030 shares during the period. Hedge funds and other institutional investors own 15.02% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the company. Morgan Stanley reiterated an "overweight" rating on shares of Relx in a report on Wednesday, April 16th. StockNews.com cut shares of Relx from a "buy" rating to a "hold" rating in a report on Tuesday, March 4th. The Goldman Sachs Group assumed coverage on shares of Relx in a research report on Wednesday, March 26th. They issued a "buy" rating for the company. Barclays raised Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. Finally, Redburn Atlantic initiated coverage on Relx in a report on Wednesday, January 8th. They set a "buy" rating on the stock. One research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Buy".

Relx Stock Down 0.8 %

NYSE RELX traded down $0.40 during trading on Wednesday, reaching $52.70. 902,407 shares of the company's stock were exchanged, compared to its average volume of 719,571. The company has a 50 day moving average price of $49.41 and a two-hundred day moving average price of $48.09. The stock has a market cap of $97.54 billion, a P/E ratio of 28.33, a price-to-earnings-growth ratio of 2.73 and a beta of 0.84. Relx Plc has a 1 year low of $40.25 and a 1 year high of $53.15. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52.

Relx Increases Dividend

The business also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Friday, May 9th will be paid a $0.5586 dividend. This is a positive change from Relx's previous semi-annual dividend of $0.23. This represents a yield of 1.6%. The ex-dividend date of this dividend is Friday, May 9th. Relx's dividend payout ratio is currently 59.68%.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.